Comparison of terbinafine 250 mg and terbinafine 500 mg tablet in the treatment of tinea corporis and tinea cruris
Not Applicable
- Conditions
- Health Condition 1: null- tinea corporis and tinea cruris
- Registration Number
- CTRI/2018/07/015131
- Lead Sponsor
- no nsuch
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients with extensive tinea corporis/cruris who are off treatment for the last 1 month will be included.
Exclusion Criteria
non consenting patients and Patients whose routine investigations reveal deranged LFT will be excluded from the study patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method